Charles Schwab’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,013
| Closed | -$8.26K | – | 3565 |
|
|
2024
Q2 | $8.26K | Hold |
11,013
| – | – | ﹤0.01% | 3619 |
|
|
2024
Q1 | $11.7K | Hold |
11,013
| – | – | ﹤0.01% | 3456 |
|
|
2023
Q4 | $11.6K | Hold |
11,013
| – | – | ﹤0.01% | 3516 |
|
|
2023
Q3 | $12.3K | Hold |
11,013
| – | – | ﹤0.01% | 3550 |
|
|
2023
Q2 | $16.6K | Hold |
11,013
| – | – | ﹤0.01% | 3577 |
|
|
2023
Q1 | $17.2K | Hold |
11,013
| – | – | ﹤0.01% | 3516 |
|
|
2022
Q4 | $7.02K | Hold |
11,013
| – | – | ﹤0.01% | 3540 |
|
|
2022
Q3 | $15K | Sell |
11,013
-86,554
| -89% | -$118K | ﹤0.01% | 3493 |
|
|
2022
Q2 | $217K | Sell |
97,567
-19,082
| -16% | -$42.4K | ﹤0.01% | 3231 |
|
|
2022
Q1 | $723K | Sell |
116,649
-9,343
| -7% | -$57.9K | ﹤0.01% | 2978 |
|
|
2021
Q4 | $1.59M | Buy |
125,992
+1,841
| +1% | +$23.2K | ﹤0.01% | 2773 |
|
|
2021
Q3 | $11.4M | Buy |
124,151
+18,304
| +17% | +$1.68M | ﹤0.01% | 1930 |
|
|
2021
Q2 | $5.61M | Buy |
105,847
+10,000
| +10% | +$530K | ﹤0.01% | 2293 |
|
|
2021
Q1 | $3.45M | Buy |
95,847
+3,598
| +4% | +$130K | ﹤0.01% | 2467 |
|
|
2020
Q4 | $2.56M | Buy |
92,249
+207
| +0.2% | +$5.75K | ﹤0.01% | 2527 |
|
|
2020
Q3 | $4.6M | Buy |
92,042
+35,191
| +62% | +$1.76M | ﹤0.01% | 2098 |
|
|
2020
Q2 | $2.63M | Buy |
56,851
+13,176
| +30% | +$610K | ﹤0.01% | 2320 |
|
|
2020
Q1 | $1.99M | Buy |
43,675
+684
| +2% | +$31.2K | ﹤0.01% | 2278 |
|
|
2019
Q4 | $2.41M | Buy |
42,991
+18,456
| +75% | +$1.04M | ﹤0.01% | 2362 |
|
|
2019
Q3 | $612K | Sell |
24,535
-207
| -0.8% | -$5.16K | ﹤0.01% | 2721 |
|
|
2019
Q2 | $1.05M | Buy |
+24,742
| New | +$1.05M | ﹤0.01% | 2559 |
|